Support for new malaria vaccine may be lacking in rich world – MENAFN.COM

(MENAFN – Asia Times) Lost in the deluge of news about Covid-19 vaccines have been the momentous strides made recently in fighting other major health challenges. Among these is malaria.
In April, it was announced that a vaccine developed at the University of Oxford’s Jenner Institute had achieved 77% efficacy in trials. While we may still be several years from an effective guard against a disease that afflicts more than 200 million people each year, there is a sense that we’re significantly closer…

Click here to view the original article.